Arvinas (ARVN) Retained Earnings (2017 - 2026)

Arvinas' (ARVN) quarterly Retained Earnings came in at $2.1 billion in Q1 2026, up 143166.67% year-on-year from N/an in Q1 2025, and up 178983.33% quarter-over-quarter from $1.2 million in Q4 2025.

Arvinas (ARVN) Retained Earnings (2017 - 2026) Analysis & Trends

Arvinas' Retained Earnings history runs 10 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 143166.67% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 143166.67% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 100.08% from the prior year.
  • Retained Earnings advanced to $2.1 billion in Q1 2026 per ARVN's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $2.1 billion in Q1 2026 and bottomed at -$1.5 billion in Q4 2024.
  • The 5-year median for Retained Earnings is $1.2 million (2025), against an average of $337.7 million.
  • Biggest YoY gain for Retained Earnings was 310205.56% in 2022; the steepest drop was 317.39% in 2022.
  • Year by year, Retained Earnings stood at -$19.2 million in 2022, then soared by 10494.27% to $2.0 billion in 2023, then sank by 176.75% to -$1.5 billion in 2024, then soared by 100.08% to $1.2 million in 2025, then jumped by 178983.33% to $2.1 billion in 2026.
  • Per Business Quant, the three latest ARVN Retained Earnings figures stand at $2.1 billion (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -527.87 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -27.89 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -279.01 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 12.91 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -622,000.00
10 Arvinas 512.64 Mn -102.26 Mn - 2.15 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.15 Bn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 2.12 Bn
Mar 31, 2025 1.50 Mn
Dec 31, 2024 -1.53 Bn
Sep 30, 2024 2.07 Bn
Jun 30, 2024 -1.44 Bn
Mar 31, 2024 -4.40 Mn
Dec 31, 2023 2.00 Bn
Sep 30, 2023 1.64 Bn
Jun 30, 2023 -1.11 Bn
Mar 31, 2023 -12.60 Mn
Dec 31, 2022 -19.20 Mn
Sep 30, 2022 -882.50 Mn
Jun 30, 2022 1.51 Bn
Mar 31, 2022 -746.30 Mn
Dec 31, 2021 -4.60 Mn
Sep 30, 2021 1.45 Bn
Jun 30, 2021 -486,544.00